Delivery formulations

Digital revolution transforming drug development: West Pharma

18-Oct-2021 By Jenni Spinner

A leader from the drug development and manufacturing firm talks about the ways in which advanced digital tools stand to revolutionize the pharma field.

AAPS PharmSci 360

PharmSci 360 invites industry pros to ‘rethink and evolve’

14-Oct-2021 By Jenni Spinner

The conference (with online and in-person content) is slated to gather professionals for deep conversations and lively collaboration on important topics.

CytoReason, Summit tap into AI on Japanese drug development effort

12-Oct-2021 By Jenni Spinner

The AI technology firm and pharma services company are joining to help one of the country’s leading pharmaceutical firms develop a promising drug candidate.

Data advances, environmental factors driving device innovation: Pharmapack

11-Oct-2021 By Jenni Spinner

Organizers of the drug delivery and packaging event have shared an industry report that reveals what is likely to push innovation forward in the future.

Generics price fixing charges land pharma firms $447.2m penalty

05-Oct-2021 By Jenni Spinner

The US Department of Justice reports three generic drug manufacturers have been socked with the hefty fine to resolve alleged False Claims Act violations

Merck: COVID-19 oral antiviral drug reduces risk of death

01-Oct-2021 By Jenni Spinner

The pharma firm reports molnupiravir was shown to cut risk of hospitalization or death by 50% compared to placebos in a positive interim Phase III analysis.

Merck to acquire Acceleron Pharma, strengthening cardiovascular pipeline

30-Sep-2021 By Rachel Arthur

Merck (MSD outside the US and Canada) will acquire Acceleron in a deal worth around $11.5bn.

Update on FDA COVID approvals, actions, and advice

24-Sep-2021 By Jenni Spinner

As COVID-19 and its variants continue their attack, the agency maintains its position of overseer and giver of advice on various treatments and vaccines.

FDA approves IND application for peanut allergy drug candidate

16-Sep-2021 By Jenni Spinner

The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.

GSK rhinosinusitis drug receives thumbs up from the FDA

09-Sep-2021 By Jenni Spinner

Nucala, a monoclonal antibody indicated for patients with chronic rhinosinusitis with nasal polyps, has been approved by the Food and Drug Administration.

Inflammasome develops combo HIV/birth control implant

23-Aug-2021 By Jenni Spinner

Thanks in part to grants from the Gates Foundation, the company has come up with a bioerodible implant that combines HIV prevention and birth control.

SPI launches UltraBurst excipient designed for ODT formulation

18-Aug-2021 By Jenni Spinner

The pjarmaceutical excipient, intended for use in the formulation of flash orally dissolving tablets, is designed to disintegrate in less than 10 seconds.

Orally disintegrating tablets offer range of patient benefits: Roquette

18-Aug-2021 By Jenni Spinner

A leader from the excipients firm discusses how ODTs appeal to seniors and patients on the go, and the formulation-related challenges with such tablets.

Secure pharma supply chain requires connections, information

18-Aug-2021 By Jenni Spinner

A representative from Clarivate explains how supply chain vulnerabilities can hurt stakeholders, including patients—and how one solution can close the gap.

Philip Morris acquires another inhaled-drug pharma firm

10-Aug-2021 By Jenni Spinner

The US-based company continues its move away from smoking products with the purchase of drug developer OtiTopic, as part of its Beyond Nicotine initiative.